Medexus Pharmaceuticals Inc News - MDP

Medexus to Participate in the 33rd Annual ROTH Conference on March 15-17, 2021

TORONTO, CHICAGO and MONTREAL, March 08, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company”...

Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021

TORONTO, CHICAGO and MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company”...

Medexus Announces Expanded Availability of Gleolan® in Canada

TORONTO and CHICAGO and MONTREAL, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the...

Medexus Schedules Third Quarter Fiscal 2021 Conference Call

TORONTO and CHICAGO and MONTREAL, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the...

Medexus Announces Closing of $32.5 Million Public Offering, Including Exercise in Full of Over-Allotment Option

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO...

Medexus to Present at the Winter Wonderland Conference- Best Ideas from the Buy-Side

TORONTO, CHICAGO and MONTREAL, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company”...

L'OCRCVM permet la reprise de la négociation - MDP

L'OCRCVM permet la reprise de la négociation - MDP Canada NewsWire VANCOUVER, BC, le 3 févr. 2021 VANCOUVER, BC, le 3 févr. 2021...

IIROC Trading Resumption - MDP

IIROC Trading Resumption - MDP Canada NewsWire VANCOUVER, BC, Feb. 3, 2021 VANCOUVER, BC, Feb. 3, 2021 /CNW/ - Trading resumes in: Company:...

Medexus Announces Upsize to Previously Announced Bought Deal Public Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO...

L'OCRCVM permet la reprise de la négociation - MDP

L'OCRCVM permet la reprise de la négociation - MDP Canada NewsWire VANCOUVER, BC, le 2 févr. 2021 VANCOUVER, BC, le 2 févr. 2021...

IIROC Trading Resumption - MDP

IIROC Trading Resumption - MDP Canada NewsWire VANCOUVER, BC, Feb. 2, 2021 VANCOUVER, BC, Feb. 2, 2021 /CNW/ - Trading resumes in: Company:...

Medexus Announces $20 Million Bought Deal Public Offering of Units

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO...

Suspension de la négociation par l'OCRCVM - MDP

Suspension de la négociation par l'OCRCVM - MDP Canada NewsWire VANCOUVER, BC, le 2 févr. 2021 VANCOUVER, BC, le 2 févr. 2021 /CNW/...

IIROC Trading Halt - MDP

IIROC Trading Halt - MDP Canada NewsWire VANCOUVER, BC, Feb. 2, 2021 VANCOUVER, BC, Feb. 2, 2021 /CNW/ - The following issues have been halted by...

Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic...

Orphan Designated Drug with August 2021 PDUFA date Management to host conference call at 10:00 AM Eastern Time...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Medexus Pharmaceuticals Inc (MDP)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

MDP News

Medexus to Participate in the 33rd Annual ROTH Conference on March 15-17, 2021

Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021

Medexus Announces Expanded Availability of Gleolan® in Canada

Medexus Schedules Third Quarter Fiscal 2021 Conference Call

Medexus Announces Closing of $32.5 Million Public Offering, Including Exercise in Full of Over-Allotment Option

Medexus to Present at the Winter Wonderland Conference- Best Ideas from the Buy-Side

L'OCRCVM permet la reprise de la négociation - MDP

IIROC Trading Resumption - MDP

Medexus Announces Upsize to Previously Announced Bought Deal Public Offering

L'OCRCVM permet la reprise de la négociation - MDP

IIROC Trading Resumption - MDP

Medexus Announces $20 Million Bought Deal Public Offering of Units

Suspension de la négociation par l'OCRCVM - MDP

IIROC Trading Halt - MDP

Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic...

MDP Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Medexus Pharmaceuticals Inc (MDP) News

Medexus Pharmaceuticals Inc (MDP)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

MDP News

Medexus to Participate in the 33rd Annual ROTH Conference on March 15-17, 2021

Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021

Medexus Announces Expanded Availability of Gleolan® in Canada

Medexus Schedules Third Quarter Fiscal 2021 Conference Call

Medexus Announces Closing of $32.5 Million Public Offering, Including Exercise in Full of Over-Allotment Option

Medexus to Present at the Winter Wonderland Conference- Best Ideas from the Buy-Side

L'OCRCVM permet la reprise de la négociation - MDP

IIROC Trading Resumption - MDP

Medexus Announces Upsize to Previously Announced Bought Deal Public Offering

L'OCRCVM permet la reprise de la négociation - MDP

IIROC Trading Resumption - MDP

Medexus Announces $20 Million Bought Deal Public Offering of Units

Suspension de la négociation par l'OCRCVM - MDP

IIROC Trading Halt - MDP

Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic...

MDP Discussion

Your Recent History